Drugs and Pharmaceutical, Drugs and Medicine, Medicine
Tender Overview
Project Description
Supply Of Medicine :- Anti-Hemophilia Clotting Factor Ix; Recombinant Lyophilized Injection For Human Use, 1 In Vial Containing 500 Iu / 600 Iu Ot Clotting Ractor Ix, For Intravenous Use, With Stability At Room Temperature! 2-8 Degree Celsius. Inj 50O Iu / 6O0 Iu Per Vial Anti-Hemophilia Clotting Factor Viil; Recombinant Lyophilized Injection For Human 2 Use, In Vial Containing 2Soiu Ot Clotting Ractor Viii, For Intravenous Use, With Stability At Room Temperature! 2-8 Degree Celsius. Inj 25O Iu Anti-Haemophilia Clotting Factorviii / Vwfvon Willebrand Factor, Plasma- Derived 3 Lyophilized Injection For Human Use, In Vial Containing 2So1u Ot Clotting Ractor Viii Rich In Vwf Von Willebrand Factorror Intravenous Use Cwith Stability At Room Temperature! Inhibitor Bypassing Anti-Haemophilia Factors; Activated Recombinant Clotting Factor 4 Vii ( Rfviia ) Lyophilized Injection For Human Use, In Vial Containing 1 Mg Activated Clotting Factor Vila Per Vial, For Intravenous Use, Stability At Room Temperature! 2-8 Inhibitor Bypassing Anti-Haemophi L Ia Factors: Anti-Lnhibitor Coagulant Complex: Apcc L 5 Lyophilized Injection For Human Use, 500 Units Per Vial For Intravenous Use, Stability At Room_Temperature!_2-8_Degree_Celsius._Inj.50O_Iu_Vial
AI Tender Summary
Tender Timeline
Tender Published
Tender notice published.
CompletedBid Submission Deadline
Online submission via eProcurement portal.
CompletedBid Opening Date
Technical bids will be opened and evaluated.
CompletedTender Documents
Download All (ZIP) ↓We takes all possible care for accurate & authentic tender information. However users are requested to refer Original source of Tender Notice / Tender Document published by Tender Issuing Agency before taking any call regarding this tender